Search Result "fluorescein isothiocyanate (FITC)-coupled goat"


The Phosphodiesterase III Inhibitor Cilostazol Ameliorates Ethanolinduced Endothelial Dysfunction

Journal: Current Neurovascular Research
Volume: 11 Issue: 4 Year: 2014 Page: 302-311
Author(s): Toshinori Takagi, Keisuke Mishiro, Masamitsu Shimazawa, Shinichi Yoshimura, Toru Iwama, Hideaki Hara

Research Article

Pseudo-ginsenoside Rh2 Induces Protective Autophagy in Hepatocellular Carcinoma HepG2 Cells

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 16 Issue: 0 Year: 2021 Page: 1-12
Author(s): Fuyuan Zhang,Huali Xu,Rui Xia,Ping Yu,Yuangeng Li,Xiaofeng Yu,Dayun Sui

Research Article

Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin-Resistant Gastric Cancer SGC7901/DDP Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 2 Year: 2022 Page: 270-279
Author(s): Dongmei Zhan,Tengyang Ni,Haibo Wang,Mengying Lv,Masataka Sunagawa,Yanqing Liu

Tissue Transglutaminase Expression During Neural Differentiation of Human Mesenchymal Stem Cells

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14 Issue: 1 Year: 2015 Page: 24-32
Author(s): Luca Vanella,Giuseppina Raciti,Ignazio Barbagallo,Roberta Bonfanti,Nader Abraham,Agata Campisi

Chronic Deposition of Aβ Influences Microcirculation in the Chronic Stage of Cerebral Ischemia

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 13 Issue: 1 Year: 2013 Page: 77-80
Author(s): Munehisa Shimamura, Naoyuki Sato, Hironori Nakagami, Mariana Kiomy Osako, Mariko Kyutoku, Kouji Wakayama, Ryuichi Morishita

Effectiveness of Two Novel Anionic and Cationic Platinum Complexes in the Treatment of Osteosarcoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 3 Year: 2015 Page: 390-399
Author(s): Kentaro Igarashi,Norio Yamamoto,Katsuhiro Hayashi,Akihiko Takeuchi,Shinji Miwa,Akira Odani,Hiroyuki Tsuchiya

The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on CD34+/CD38+ and CD34+/CD38- AML Progenitor Cells

Journal: Current Cancer Drug Targets
Volume: 12 Issue: 1 Year: 2012 Page: 51-63
Author(s): H. Herrmann, M. Kneidinger, S. Cerny-Reiterer, T. Rulicke, M. Willmann, K. V. Gleixner, K. Blatt, G. Hormann, B. Peter, P. Samorapoompichit, W. Pickl, G. Y. Bharate, M. Mayerhofer, W. R. Sperr, H. Maeda, P. Valent

Hyperglycemia Regulates TXNIP/TRX/ROS Axis via p38 MAPK and ERK Pathways in Pancreatic Cancer

Journal: Current Cancer Drug Targets
Volume: 14 Issue: 4 Year: 2014 Page: 348-356
Author(s): Wei Li,Zheng Wu,Qingyong Ma,Jiangbo Liu,Qinhong Xu,Liang Han,Wanxing Duan,Yunfu Lv,Fengfei Wang,Katie M. Reindl,Erxi Wu

Research Article

Doxorubicin-Loaded Micelle Targeting MUC1: A Potential Therapeutic for MUC1 Triple Negative Breast Cancer Treatment

Journal: Current Drug Delivery
Volume: 15 Issue: 3 Year: 2018 Page: 406-416
Author(s): Supang Khondee,Chuda Chittasupho,Singkome Tima,Songyot Anuchapreeda

T-Cell Antigen Receptor Assembly and Cell Surface Expression Is Not Affected by Treatment with T-Cell Antigen Receptor-Alpha Chain Transmembrane Peptide

Journal: Protein & Peptide Letters
Volume: 14 Issue: 3 Year: 2007 Page: 299-303
Author(s): Nozomu Kurosaka, Andrea Bolte, Marina Ali, Nicholas Manolios

Previous   Next

Go To   Results 1 - 1 of 30

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy